Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation.
Shen B, Wu N, Shen C, Zhang F, Wu Y, Xu P, Zhang L, Wu W, Lu Y, Han J, Wang Y, Yuan H.
Shen B, et al. Among authors: wu y, wu w, wu n.
Drug Dev Ind Pharm. 2016 Nov;42(11):1772-81. doi: 10.3109/03639045.2016.1173051. Epub 2016 Apr 24.
Drug Dev Ind Pharm. 2016.
PMID: 27032257